Lipids Flashcards
Give 5 modifiable cardiovascular risk factors
smoking high cholesterol high BP Obesity diabetes lack of exercise excess alcohol
Give 3 non-modifiable risk factors for cardiovascular disease
Fhx
gender
age
ethnicity
3 roles of cholesterol in the body
repair of cell membranes
synthesis of steroid hormones
synthesis of vitamin D
synthesis of bile acids
describe the exogenous pathway of lipid metabolism
The exogenous metabolic pathway is concerned with the transport and utilisation of dietary fats.
Chylomicrons (transport triglyceride from gut to liver) are formed, which enter the blood stream via intestinal lymphatics and thoracic duct.
chylomicron is hydrolysed and releases its triglyceride core, FFAs and mono and diglycerides
chylomicron remnant is transported to the liver and is degraded.
describe the endogenous pathway of lipid metabolism
Triglycerides together with cholesterol, cholesteryl ester and other lipids are transported in VLDL in the bloodstream, where VLDL undergoes delipidation with the enzyme lipoprotein lipase in a similar way to chylomicrons; this is the endogenous pathway of lipid metabolism.
Small dense LDL particles are the most atherogenic
3 secondary causes of hyperlipidaemia
Hypothyroidism Diabetes Renal disease Liver disease Excess alcohol
2 clinical signs O/E for hyperlipidaemia
xanthelasma
xanthomata
Baseline Ix for pt with lipid disorders
Lipid profile (TC, LDL, HDL, Triglyceride and non-HDL) Liver function tests and Gamma-GT Fasting glucose / HbA1c Thyroid Function test Urine dipstick Renal Function test
name 3 genes involved in familial hypercholesterolaemia
LDLR
APOB
PCSK9
Diagnosis of familial hypercholesterolaemia
Simon Broome Criteria (NICE guideline)
Total cholesterol > 7.5 mmol/L
Low density lipoprotein cholesterol (LDL-C) > 4.9
Family history
-Premature coronary artery disease (<60 years)
-Hypercholesterolaemia
3 clinical signs o/e for hypercholesterolaemia
tendon xanthoma
corneal arcus
xanthelasma
3 categories of Mx of hyperlipidaemia
lifestyle
statins
other lipid lowering drugs
How do PCSK9 inhibitors work?
LDLR recycling: LDL receptor binds to cholesterol, is taken into the liver cell, the cholesterol is unbound and the receptor moves back to the cell membrane
PCSK9 attaches to the receptor and takes it into the cell and keeps it there- this means that there are fewer LDLR to take the cholesterol out of the blood stream. PCSK9 inhibitors are new drugs used in the treatment of hypercholesterolaemia.
What is used to assess cardiovascular risk score?
QRISK
What are the 3 types of troponin
T- tropomyosin binding
I- inhibitory protein
C- calcium binding